189 related articles for article (PubMed ID: 36454190)
1. Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis.
Hao Y; Song K; Tan X; Ren L; Guo X; Zhou C; Li H; Wen J; Meng Y; Lin M; Zhang Y; Huang H; Wang L; Zheng W
ACS Nano; 2022 Dec; 16(12):20739-20757. PubMed ID: 36454190
[TBL] [Abstract][Full Text] [Related]
2. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis.
Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y
Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933
[TBL] [Abstract][Full Text] [Related]
3. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Wang X; Zhang W; Zeng S; Wang L; Wang B
Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
[TBL] [Abstract][Full Text] [Related]
4. Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis.
Li S; Ren QJ; Xie CH; Cui Y; Xu LT; Wang YD; Li S; Liang XQ; Wen B; Liang MK; Zhao XF
World J Gastroenterol; 2024 Apr; 30(15):2143-2154. PubMed ID: 38681990
[TBL] [Abstract][Full Text] [Related]
5. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles.
Xiang L; Wang X; Jiao Q; Shao Y; Luo R; Zhang J; Zheng X; Zhou S; Chen Y
Acta Biomater; 2023 Sep; 168():497-514. PubMed ID: 37507035
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy.
Fan QQ; Zhang CL; Qiao JB; Cui PF; Xing L; Oh YK; Jiang HL
Biomaterials; 2020 Feb; 230():119616. PubMed ID: 31837823
[TBL] [Abstract][Full Text] [Related]
8. Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo.
Li Q; Ding Y; Guo X; Luo S; Zhuang H; Zhou J; Xu N; Yan Z
J Cell Mol Med; 2019 Mar; 23(3):1951-1962. PubMed ID: 30592139
[TBL] [Abstract][Full Text] [Related]
9. Impact of Reverse Micelle Loaded Lipid Nanocapsules on the Delivery of Gallic Acid into Activated Hepatic Stellate Cells: A Promising Therapeutic Approach for Hepatic Fibrosis.
Radwan SAA; El-Maadawy WH; ElMeshad AN; Shoukri RA; Yousry C
Pharm Res; 2020 Sep; 37(9):180. PubMed ID: 32875435
[TBL] [Abstract][Full Text] [Related]
10. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis.
Li R; Li Z; Feng Y; Yang H; Shi Q; Tao Z; Cheng J; Lu X
Apoptosis; 2020 Feb; 25(1-2):105-119. PubMed ID: 31894448
[TBL] [Abstract][Full Text] [Related]
11. Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.
Oh Y; Park O; Swierczewska M; Hamilton JP; Park JS; Kim TH; Lim SM; Eom H; Jo DG; Lee CE; Kechrid R; Mastorakos P; Zhang C; Hahn SK; Jeon OC; Byun Y; Kim K; Hanes J; Lee KC; Pomper MG; Gao B; Lee S
Hepatology; 2016 Jul; 64(1):209-23. PubMed ID: 26710118
[TBL] [Abstract][Full Text] [Related]
12. Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation.
Huang J; Huang H; Wang Y; Xu B; Lin M; Han S; Yuan Y; Wang Y; Shuai X
Biomaterials; 2023 Aug; 299():122134. PubMed ID: 37167895
[TBL] [Abstract][Full Text] [Related]
13. A bilirubin-conjugated chitosan nanotheranostics system as a platform for reactive oxygen species stimuli-responsive hepatic fibrosis therapy.
Surendran SP; Thomas RG; Moon MJ; Park R; Lee JH; Jeong YY
Acta Biomater; 2020 Oct; 116():356-367. PubMed ID: 32927089
[TBL] [Abstract][Full Text] [Related]
14. Comment on "Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis".
Sun X; Jiang X
ACS Nano; 2023 Mar; 17(5):4094-4095. PubMed ID: 36916179
[No Abstract] [Full Text] [Related]
15. Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats.
Du SL; Pan H; Lu WY; Wang J; Wu J; Wang JY
J Pharmacol Exp Ther; 2007 Aug; 322(2):560-8. PubMed ID: 17510318
[TBL] [Abstract][Full Text] [Related]
16. Reply to "Comment on 'Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis'".
Hao Y; Song K; Tan X; Zhang Y; Wang L; Zheng W
ACS Nano; 2023 Mar; 17(5):4096-4097. PubMed ID: 36916180
[No Abstract] [Full Text] [Related]
17. Golgi Apparatus-Targeted Chondroitin-Modified Nanomicelles Suppress Hepatic Stellate Cell Activation for the Management of Liver Fibrosis.
Luo J; Zhang P; Zhao T; Jia M; Yin P; Li W; Zhang ZR; Fu Y; Gong T
ACS Nano; 2019 Apr; 13(4):3910-3923. PubMed ID: 30938986
[TBL] [Abstract][Full Text] [Related]
18. Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth.
Birukawa NK; Murase K; Sato Y; Kosaka A; Yoneda A; Nishita H; Fujita R; Nishimura M; Ninomiya T; Kajiwara K; Miyazaki M; Nakashima Y; Ota S; Murakami Y; Tanaka Y; Minomi K; Tamura Y; Niitsu Y
J Biol Chem; 2014 Jul; 289(29):20209-21. PubMed ID: 24867951
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Stellate Cell-Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis.
Wang L; Zhou J; Wang J; Wang X; Dong H; Zhao L; Wu J; Peng J
Adv Healthc Mater; 2024 May; 13(12):e2303710. PubMed ID: 38293743
[TBL] [Abstract][Full Text] [Related]
20. Hepatic stellate cells specific liposomes with the Toll-like receptor 4 shRNA attenuates liver fibrosis.
Zhang Y; Li Y; Mu T; Tong N; Cheng P
J Cell Mol Med; 2021 Jan; 25(2):1299-1313. PubMed ID: 33336563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
